Ibrutinib deacryloylpiperidine |
Catalog No.GC60197 |
L'ibrutinib désacryloylpipéridine (IBT4A) est une impureté de l'ibrutinib. L'ibrutinib est un inhibiteur sélectif et irréversible de la Btk avec une IC50 de 0,5 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 330786-24-8
Sample solution is provided at 25 µL, 10mM.
Ibrutinib deacryloylpiperidine (IBT4A) is an impurity of Ibrutinib[1]. Ibrutinib is a selective, irreversible Btk inhibitor with an IC50 of 0.5 nM[2].
[1]. Somana Siva Prasad, et al. A QUALITY BY DESIGN APPROACH FOR DEVELOPMENT OF SIMPLE AND ROBUST REVERSED PHASE STABILITY INDICATING HPLC METHOD FOR ESTIMATION OF IBRUTINIB AND ITS IMPURITIES. [2]. Honigberg LA, et al. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13075-80.
Average Rating: 5
(Based on Reviews and 6 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *